The combination of modular facilities and closed processing offers significant advantages in the production of biopharmaceuticals and is becoming a compelling option for manufacturing.
Sarah Le Merdy
Advertisement
Sarah Le Merdy is Systems and Single-Use Global Strategy Deployment Manager at Life Science business of Merck KgaA, Darmstadt, Germany.
Articles by Sarah Le Merdy
Advertisement
Latest Updated Articles
Perceptions and Considerations for Adopting Closed ProcessingPublished: April 13th 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
5
